CareLit Fachartikel

High Rates of Comorbidities and Polypharmacy in Patients with Chronic Hepatitis C in Germany: Results of a large cross-sectional study

S Christensen, F Marra, K Kostev · Zeitschrift für Gastroenterologie · 2015 · Heft 08

Dokument
1084513
CareLit-ID
Jahr
2015
Publikation
PDF
nein
Metadaten
DOI
ja
zitierfähig

Bibliografische Angaben

Zeitschrift
Zeitschrift für Gastroenterologie
Autor:innen
S Christensen, F Marra, K Kostev
Ausgabe
Heft 08 / 2015
Seiten
–
Erschienen: 2015-08-18 00:00:00
ISSN
0044-2771
DOI
10.1055/s-0035-1559166

Zusammenfassung

Background: The potential future healthcare burden of hepatitis C is now generally accepted. More patients will be able to benefit from cure with newly approved direct-acting antiviral agents (DAA); however, there is evidence of potential for drug-drug interactions (DDI). We investigated the demographics, prevalence of co-morbidities and co-medications with DDI potential among chronic hepatitis C (CHC) patients in Germany. Methods: This large cross-sectional study analysed electronic patient records from 737 general practitioners (GP) and 36 gastroenterologists in Germany (IMS® Disease Analyzer) during the study…

Schlagworte

Germany Hepatitis Chronic Pain Depression General Practitioners Drug Interactions Antiviral Agents Physicians Diagnosis Database Asthma Zeitschrift für Gastroenterologie